1. Home
  2. DNLI vs POR Comparison

DNLI vs POR Comparison

Compare DNLI & POR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • POR
  • Stock Information
  • Founded
  • DNLI 2013
  • POR 1889
  • Country
  • DNLI United States
  • POR United States
  • Employees
  • DNLI N/A
  • POR N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • POR Electric Utilities: Central
  • Sector
  • DNLI Health Care
  • POR Utilities
  • Exchange
  • DNLI Nasdaq
  • POR Nasdaq
  • Market Cap
  • DNLI 4.5B
  • POR 4.9B
  • IPO Year
  • DNLI 2017
  • POR N/A
  • Fundamental
  • Price
  • DNLI $25.05
  • POR $46.67
  • Analyst Decision
  • DNLI Strong Buy
  • POR Buy
  • Analyst Count
  • DNLI 11
  • POR 8
  • Target Price
  • DNLI $38.90
  • POR $48.86
  • AVG Volume (30 Days)
  • DNLI 788.0K
  • POR 1.0M
  • Earning Date
  • DNLI 11-06-2024
  • POR 10-25-2024
  • Dividend Yield
  • DNLI N/A
  • POR 4.29%
  • EPS Growth
  • DNLI N/A
  • POR 51.49
  • EPS
  • DNLI N/A
  • POR 3.35
  • Revenue
  • DNLI N/A
  • POR $3,341,000,000.00
  • Revenue This Year
  • DNLI N/A
  • POR $7.73
  • Revenue Next Year
  • DNLI $283.75
  • POR $4.67
  • P/E Ratio
  • DNLI N/A
  • POR $13.93
  • Revenue Growth
  • DNLI 204.74
  • POR 15.81
  • 52 Week Low
  • DNLI $14.56
  • POR $39.14
  • 52 Week High
  • DNLI $33.33
  • POR $49.85
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 37.93
  • POR 45.95
  • Support Level
  • DNLI $26.17
  • POR $45.84
  • Resistance Level
  • DNLI $33.33
  • POR $47.78
  • Average True Range (ATR)
  • DNLI 1.64
  • POR 0.85
  • MACD
  • DNLI -0.13
  • POR -0.10
  • Stochastic Oscillator
  • DNLI 0.66
  • POR 37.01

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About POR Portland General Electric Co

Portland General Electric is a regulated electric utility providing generation, transmission, and distribution services in a service territory that includes about half of all Oregon residents and two thirds of the state's business activity. The company owns (wholly or through joint ventures) 3.5 gigawatts of gas, coal, wind, and hydro generation.

Share on Social Networks: